NEWARK, Del.--(Business Wire)--
PicksThatMove is pleased to bring investors special situation stocks which have
a high potential for price appreciation. These companies have interesting
business models and they have to execute on the business development level to
bring value to shareholders. Some of our past picks had soared over 200%. To
view some of our profiled stocks, please visit our website at
www.picksthatmove.com.
At PicksThatMove, our team scours the technical and financials of hundreds of
companies to identify those stocks showing the greatest potential for growth.
The investment opinions offered below and in this press release are provided by
Nick Hunter, RIA, of PicksThatMove.com
Human Genome Science Inc. (NASADQ: HGSI), $24.30, +$5.61, 30.02%, - saw its
shares surge this today with over 38 million shares traded so far. The company
announced that its drug Benlysta met the standards of BLISS-76, the second of
two key Phase 3 trials in patients with systemic lupus erythematosus (SLE).
Lupus is a disease where the body`s tissues are attacked by the immune system
which results in chronic inflammation of the various tissues and organs of the
body. It is being reported that the company plans on asking for regulator
approval in 2010, and this could be the first treatment approved for patients
with SLE in decades. Human Genome Science is a commercially focused
biopharmaceutical company.
General Electric Company (NYSE: GE), $14.44, +$0.18, 1.26%, is making gains
today with over 88 million shares traded. GE, a technology, media and financial
services company provides products and services ranging from aircraft engines to
medical imaging. The company announced today its technology development arm, GE
Global Research, has been awarded a two-year, $1.2 million project to develop a
low-cost transducer for portable ultrasound systems without compromising the
image quality. This new development falls within GE`s healthymagination program
with its aim to lower costs and provide more technological advances to
underserved communities worldwide.
eBay Inc. (NASDAQ: EBAY), $22.41, $+0.14, 0.63%, is up $0.14 on no news and with
over 19 million shares traded so far. Last month`s report released by the
company confirmed its Q3 results with revenue of $2.2 billion, up $120.3 million
from the same period of last year. The company contributes its rise in earnings
to the continued growth among others to PayPal and Skype. eBay is an online
marketplace for the purchase and sale of goods and services.
NovaDel Pharma Inc. (AMEX: NVD), $0.308, +$0.057, 22.47%, has made gains of over
22% today. The company announced last week that it has entered into a licensing
agreement with Mist Acquisition, LLC, a privately held company to manufacture
and commercialize the NitroMistR lingual spray version of nitroglycerine, a
common treatment of angina pectoris. Under the terms, Mist will pay NovaDel a
$1,000,000 licensing fee upon the execution of the agreement. Complete payment
details are available on the company`s website. NovaDel is a pharmaceutical
company responsible for developing oral spray formulations for a broad range of
marketed drugs.
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN), $12.08, +$1.04, 9.42%, is making
significant gains today after it was announced that the U.S. Food and Drug
Administration has approved an expanded indication for BYETTA (exenatide)
injection. BYETTA has now received approval for use as medication that can be
used alone along with recommended diet and exercise to improve glycemic control
in adults with type 2 diabetes. It was previously being used only for patients
who were taking additional diabetes medications and had not achieved adequate
glycemic control. Amylin is a company focused on using innovative science to
offer new treatments for diabetes and obesity.
About Picksthatmove.com
PicksThatMove.com is an independent electronic publication that provides
information on selected publicly traded companies. PicksThatMove.com is not a
registered investment advisor or broker-dealer. PicksThatMove.com`s affiliates,
offices, directors and employees may buy and sell shares in any company
mentioned herein and may profit in the event those shares rise in value. Please
do your own Due Diligence before investing in any of the stocks mentioned above.
Nick Hunter, RIA, of PicksThatMove.com is a member of the National Association
of Securities Dealers, CRD number 2022366
PicksThatMove.com
Joseph Smith, 1-877-292 3917
info@picksthatmove.com
http://www.picksthatmove.com
Copyright Business Wire 2009
